ArticleScientific reports2025
Validation of the obstetric comorbidities index for predicting maternal mortality and severe maternal morbidity in South Korea.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between ovarian hyperstimulation syndrome and adverse obstetric and neonatal outcomes in Korea: a nationwide health insurance database study.Journal of assisted reproduction and genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
To validate the Obstetric Comorbidity Index (OB-CMI) and estimate its predictive and discriminative performance for maternal outcomes in the South Korean population. This study used data on births from the National Health Insurance Service Delivery Cohort database in South Korea. The data on pregnant people who gave birth during 2003-2019 were included. The obstetric comorbidities were identified using the Bateman's OB-CMI. The outcomes were severe maternal morbidity (SMM) as defined by the CDC in the US; severe acute maternal morbidity (SAMM), as defined by EURONET; and maternal death within 30 days postpartum. The predictive and discriminative abilities of the index were calculated using the Brier score and area under the receiver operating characteristic curve (AUC). Of 6,527,810 births, 143,392 (2.2%), 84,994 (1.3%), and 555 (< 0.1%) resulted in SMM, SAMM, and maternal death, respectively. The predictive ability and discriminative performance of the OB-CMI were moderate and good (Brier scores of 0.02, 0.01, and 0.00 and AUC of 0.72, 0.68, and 0.78 for SMM, SAMM, and maternal death, respectively). The OB-CMI demonstrated moderate and good predictive and discriminative performance for SMM, SAMM, and maternal mortality in the South Korean population. These findings align with previous research, supporting OB-CMI as a valuable tool for identifying high-risk pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.